D-0075-2026 Class II Ongoing
FDA drug recall D-0075-2026 was initiated by GenoGenix LLC on Jul 30, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2025
- Initiation Date
- Jul 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Elite Stack Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Medical Health Institute (MHI).
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
US Nationwide.
Code information
All lots within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0075-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026